HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study

by Marianne Harris, Bruce Ganase, Birgit Watson, P. Richard Harrigan, Julio S. G. Montaner, Mark W. Hull
Published 2017-11-01

HIV and Liver transplantation: The British Columbia Experience, 2004 to 2013

by Clara Tan-Tam, Pamela Liao, Julio S Montaner, Mark W Hull, Charles H Scudamore, Siegfried R Erb, Eric M Yoshida
Published 2014-01-01

Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study.

by Ni Gusti Ayu Nanditha, Martin St-Jean, Hiwot Tafessu, Silvia A Guillemi, Mark W Hull, Michelle Lu, Bonnie Henry, Rolando Barrios, Julio S G Montaner, Viviane D Lima
Published 2019-01-01

Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial.

by Darrell H S Tan, Maria Jose Rolon, Maria Ines Figueroa, Omar Sued, Ana Gun, Rupert Kaul, Janet M Raboud, Leah Szadkowski, Mark W Hull, Sharon L Walmsley, Pedro Cahn, Argentinean GARDEL research network
Published 2019-01-01

The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study

by Huiting Ma, Conrado Franco Villalobos, Martin St-Jean, Oghenowede Eyawo, Miriam Ruth Lavergne, Lianping Ti, Mark W. Hull, Benita Yip, Lang Wu, Robert S. Hogg, Rolando Barrios, Jean A. Shoveller, Julio S. G. Montaner, Viviane D. Lima
Published 2018-05-01